A group of students from Ghent University is currently working on an innovative project that tackles the problem of drinking water scarcity. This project, called "Dewpal," will be their entry in The International Genetically Engineered Machine (iGEM) Competition. Dewpal involves the designing and printing (using a special filament that allows for binding with external proteins) of a unique 3D shape. The combination of 3D printing and synthetic biology, i.e., functionalized 3D-printed structures, has many potential applications.
Interdisciplinary work and discussion can yield remarkable results. Fluidda has combined aerospace engineering and biomedical expertise to create a truly unique profile. [...]
From October 1st onwards, Confo Therapeutics will be led by their new CEO Dr. Cedric Ververken. Ververken joins Confo Therapeutics from Ablynx, where he most recently acted as Vice President Business Development, heading the company’s partnering activities around specific products and Nanobody drug discovery collaborations with top tier pharmaceutical companies. With the appointment of the new CEO, the company is aiming to transform Confo Therapeutics into a drug discovery and development company.